載入...
Re-purposing cancer therapeutics for breast cancer immunotherapy
After decades of work to develop immune-based therapies for cancer, the first drugs designed specifically to engage the host anti-tumor immune response for therapeutic benefit were recently approved for clinical use. Sipuleucel-T, a vaccine for advanced prostate cancer, and ipilimumab, a monoclonal...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer-Verlag
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582212/ https://ncbi.nlm.nih.gov/pubmed/22454154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1247-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|